Improved survival of type 2 diabetic patients on renal replacement therapy in Finland

被引:8
作者
Kervinen, Marjo [1 ]
Lehto, Seppo [1 ]
Ikaheimo, Risto [2 ]
Karhapaa, Pauli [1 ]
Gronhagen-Riska, Carola [3 ,4 ]
Finne, Patrik [3 ,5 ]
机构
[1] Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland
[2] Oulu Univ Hosp, Dept Internal Med, Oulu, Finland
[3] Finnish Registry Kidney Dis, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Div Nephrol, Dept Med, Helsinki, Finland
[5] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
关键词
diabetes mellitus; end-stage renal disease; survival; CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; GLYCEMIC CONTROL; CARDIAC-DISEASE; RISK; MANAGEMENT; MORTALITY; FAILURE;
D O I
10.1093/ndt/gfp555
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. Patients who entered RRT because of type 2 diabetes mellitus in 1995-99 (n = 314) and 2000-05 (n = 583) were identified within the Finnish Registry for Kidney Diseases. The two cohorts were followed up from start of RRT until death or end of follow-up on 31 December 2006. Survival probabilities and probabilities of receiving a kidney transplant were calculated using Kaplan-Meier curves. Multivariate modelling was performed using Cox regression. Results. Patients who entered RRT in 2000-05 had lower risk of dying than those who entered in 1995-99; hazard ratio (HR) was 0.76 (95% CI 0.65-0.89) and 0.74 (95% CI 0.63-0.87) with adjustment for age and gender. The decreased risk of death was most obvious in age groups 55-64 (HR 0.67, 95% CI 0.49-0.92) and 65-74 years (HR 0.69, 95% CI 0.56-0.87). Adjustment for albumin in addition to age and gender only slightly weakened the effect of study periods (HR 0.83, 95% CI 0.69-1.01). The patients in 2000-05 were more obese, had lower total and LDL cholesterol and higher HDL cholesterol and albumin concentration in serum than patients in 1995-99. Patients' probability to receive a kidney transplant was low in both groups. Conclusions. Survival of type 2 diabetes patients on RRT improved during the time period 1995-2005 in Finland while the probability of receiving a kidney transplant remained low and unchanged.
引用
收藏
页码:892 / 896
页数:5
相关论文
共 25 条
[1]   Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure [J].
Baber, Usman ;
Toto, Robert D. ;
de Lemos, James A. .
AMERICAN HEART JOURNAL, 2007, 153 (04) :471-477
[2]   RANTES gene polymorphisms redict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients [J].
Böger, CA ;
Fischereder, M ;
Deinzer, M ;
Aslanidis, C ;
Schmitz, G ;
Stubanus, M ;
Banas, B ;
Krüger, B ;
Riegger, GAJ ;
Krämer, BK .
ATHEROSCLEROSIS, 2005, 183 (01) :121-129
[3]   Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes [J].
Burnier, M ;
Zanchi, A .
JOURNAL OF HYPERTENSION, 2006, 24 (01) :11-25
[4]   The relationship between hyperinsulinemia, hypertension and progressive renal disease [J].
El-Atat, FA ;
Stas, SN ;
McFarlane, SI ;
Sowers, JR .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11) :2816-2827
[5]  
*FINN REG KIDN DIS, 2006, ANN REP 2005 FINL HE
[6]   Incidence of end-stage renal disease in patients with type 1 diabetes [J].
Finne, P ;
Reunanen, A ;
Stenman, S ;
Groop, PH ;
Grönhagen-Riska, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1782-1787
[7]   Cardiac disease in diabetic end-stage renal disease [J].
Foley, RN ;
Culleton, BF ;
Parfrey, PS ;
Harnett, JD ;
Kent, GM ;
Murray, DC ;
Barre, PE .
DIABETOLOGIA, 1997, 40 (11) :1307-1312
[8]  
Götz AK, 2005, EUR J MED RES, V10, P155
[9]   Anemia and cardiovascular disease in diabetic nephropathy [J].
McFarlane S.I. ;
Salifu M.O. ;
Makaryus J. ;
Sowers J.R. .
Current Diabetes Reports, 2006, 6 (3) :213-218
[10]   Insulin resistance and cardiovascular disease [J].
McFarlane, SI ;
Banerji, M ;
Sowers, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :713-718